Skip to content

Clinical trials

Hemophilia B trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Country / region: United States Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20053
20073
20083
20096
20103
20114
20127
20133
20148
20158
20164
201710
20189
20191
20205
20213
20224
20235
20246
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Terminated19
Recruiting12
Active, not recruiting4
Unknown status2
Withdrawn2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S13
Pfizer10
CSL Behring9
Baxalta now part of Shire7
American Thrombosis and Hemostasis Network5
Bioverativ Therapeutics Inc.5
ApcinteX Ltd3
Genzyme, a Sanofi Company3
St. Jude Children's Research Hospital3
Wyeth is now a wholly owned subsidiary of Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B102
Hemophilia A53
Hematologic Diseases7
Hemorrhage6
Blood Coagulation Disorders5
Blood Coagulation Disorders, Inherited4
Thrombosis4
Anemia, Sickle Cell3
Coagulation Protein Disorders3
Genetic Diseases, Inborn3

Trials

Showing 26 to 50 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.